DNA icon

Thrombocytopenia via the MASTL Gene

Summary and Pricing

Test Method

Exome Sequencing with CNV Detection
Test Code Test Copy GenesTest CPT Code Gene CPT Codes Copy CPT Codes Base Price
MASTL 81479 81479,81479 $990
Test Code Test Copy Genes Test CPT Code Gene CPT Codes Copy CPT Code Base Price
11463MASTL81479 81479,81479 $990 Order Options and Pricing

Pricing Comments

Our favored testing approach is exome based NextGen sequencing with CNV analysis. This will allow cost effective reflexing to PGxome or other exome based tests. However, if full gene Sanger sequencing is desired for STAT turnaround time, insurance, or other reasons, please see link below for Test Code, pricing, and turnaround time information. If the Sanger option is selected, CNV detection may be ordered through Test #600.

An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.

Click here for costs to reflex to whole PGxome (if original test is on PGxome Sequencing platform).

Click here for costs to reflex to whole PGnome (if original test is on PGnome Sequencing platform).

The Sanger Sequencing method for this test is NY State approved.

For Sanger Sequencing click here.

Turnaround Time

3 weeks on average for standard orders or 2 weeks on average for STAT orders.

Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.

Targeted Testing

For ordering sequencing of targeted known variants, go to our Targeted Variants page.


Genetic Counselors


  • Siwu Peng, PhD

Clinical Features and Genetics

Clinical Features

Autosomal dominant thrombocytopenia (OMIM 188000) is characterized by moderately low platelet counts (family averages = 40-60/nl) (Savoia et al. Am J Hum Genet 65:1401-1405, 1999; Iolascon et al. Pediatr Res 46:548-552, 1999; and Drachman et al. Blood 96:118-125, 2000). Platelets are of normal size. Patients often bruise easily and have moderate bleeding problems. Thrombopoietin levels are mildly elevated. Patients with this disorder do not progress to leukemia or to pancytopenia.


Variants in the MASTL gene cause autosomal dominant thrombocytopenia (Gandhi et al. Hum Hered 55:66-70, 2003). Variants in a similar gene in Drosophila (greatwall) cause defects in chromosome condensation and metaphase arrest. The protein PP2A dephosphorylates mitotic substrates and promotes mitosis. MASTL (greatwall) encodes a kinase that phosphorylates PP2A regulators which help control initiation and maintenance of mitosis by inhibiting PP2A function (Gharbi-Ayachi et al. Science 330: 1673-1677, 2010). To date, one causative missense variant (Asp167Glu) has been reported in humans. The frequency of this disorder may be underestimated because of the relatively mild symptoms.

Clinical Sensitivity - Sequencing with CNV PGxome

Sensitivity of this test is unknown.

Testing Strategy

This test provides full coverage of all coding exons of the MASTL gene plus 10 bases of flanking noncoding DNA in all available transcripts along with other non-coding regions in which pathogenic variants have been identified at PreventionGenetics or reported elsewhere. We define full coverage as >20X NGS reads or Sanger sequencing. PGnome panels typically provide slightly increased coverage over the PGxome equivalent. PGnome sequencing panels have the added benefit of additional analysis and reporting of deep intronic regions (where applicable).

Dependent on the sequencing backbone selected for this testing, discounted reflex testing to any other similar backbone-based test is available (i.e., PGxome panel to whole PGxome; PGnome panel to whole PGnome).

Indications for Test

Candidates for this test are patients from families with dominant thrombocytopenia who have symptoms that match those described.


Official Gene Symbol OMIM ID
MASTL 608221
Inheritance Abbreviation
Autosomal Dominant AD
Autosomal Recessive AR
X-Linked XL
Mitochondrial MT


Name Inheritance OMIM ID
Thrombocytopenia 2 AD 188000


  • Drachman JG. et al. 2000. Blood. 96: 118-25. PubMed ID: 10891439
  • Gandhi, M. J., et.al. (2003). "FLJ14813 missense mutation: a candidate for autosomal dominant thrombocytopenia on human chromosome 10." Hum Hered 55(1): 66-70. PubMed ID: 12890928
  • Geddis, A. E., Kaushansky, K. (2004). "Inherited thrombocytopenias: toward a molecular understanding of disorders of platelet production." Curr Opin Pediatr 16(1): 15-22. PubMed ID: 14758109
  • Gharbi-Ayachi, A. et al. (2010). "The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A". Science 330: 1673-1677. PubMed ID: 21164014
  • Iolascon, A., et.al. (1999). "Familial dominant thrombocytopenia: clinical, biologic, and molecular studies." Pediatr Res 46(5): 548-52. PubMed ID: 10541317
  • Savoia A. et al. 1999. American journal of human genetics. 65: 1401-5. PubMed ID: 10521306


Ordering Options

We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.

myPrevent - Online Ordering

  • The test can be added to your online orders in the Summary and Pricing section.
  • Once the test has been added log in to myPrevent to fill out an online requisition form.
  • PGnome sequencing panels can be ordered via the myPrevent portal only at this time.

Requisition Form

  • A completed requisition form must accompany all specimens.
  • Billing information along with specimen and shipping instructions are within the requisition form.
  • All testing must be ordered by a qualified healthcare provider.

For Requisition Forms, visit our Forms page

If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.

Specimen Types

Specimen Requirements and Shipping Details

PGxome (Exome) Sequencing Panel

PGnome (Genome) Sequencing Panel

loading Loading... ×


An error has occurred while calculating the price. Please try again or contact us for assistance.

View Ordering Instructions

1) Select Test Method (Platform)

1) Select Test Type

2) Select Additional Test Options

No Additional Test Options are available for this test.

Note: acceptable specimen types are whole blood and DNA from whole blood only.
Total Price: loading
Patient Prompt Pay Price: loading
A patient prompt pay discount is available if payment is made by the patient and received prior to the time of reporting.
Show Patient Prompt Pay Price
Copy Text to Clipboard